Indo Borax & Chemicals received a credit rating of IND BBB+/Stable for its ₹60 crore bank loan facilities. The company reported a 23% revenue jump but saw a dip in EBITDA margins due to higher costs and a plant shutdown.
Detailed Coverage
Indo Borax & Chemicals Gets Stable Credit Rating; Revenue Jumps 23%
Indo Borax & Chemicals Ltd. has secured a credit rating of IND BBB+/Stable for its bank loan facilities worth ₹60 crore (INR 600 million) from India Ratings.
The company's standalone status is debt-free for FY26.
Reader Takeaway: Strong revenue growth and expansion plans are positive, but promoter share pledge and margin compression are key concerns.
What just happened
India Ratings assigned Indo Borax & Chemicals Ltd. a long-term rating of IND BBB+/Stable and a short-term rating of IND A2+ for its bank loan facilities amounting to ₹60 crore. The company reported a revenue of ₹2,154.51 million for FY26, a significant 23% increase from ₹1,752.61 million in FY25. Despite the revenue growth, EBITDA saw a slight decline to ₹441.59 million from ₹458.92 million, with EBITDA margins compressing from 26.18% to 20.50%. This margin decline is attributed to increased raw material costs and a 45-day unplanned plant shutdown in the third quarter of FY26.
Why this matters
This credit rating provides formal validation of the company's financial health, which is crucial as it plans to tap the debt market for working capital. The robust revenue growth indicates strong demand for its products. However, the margin compression highlights operational challenges that need to be addressed. Investors will be watching how the company balances its expansion plans with profitability.
The backstory
Indo Borax & Chemicals holds a significant position in the boric acid market, commanding approximately 50% share in the steel/refractory segment. As of FYE26, the company maintained a strong financial position, being debt-free on a standalone basis with a healthy cash reserve of ₹2,638 million.
What changes now
The company is planning a capital expenditure (capex) of ₹90 crore over FY27-FY28, to be funded through internal accruals. This includes expanding Boric Acid capacity by 10,000 MT and setting up a 4,000 MT Boron Oxide capacity. These new facilities are expected to become operational by FY29. The credit rating will facilitate access to necessary working capital loans for ongoing operations.
Risks to watch
A significant concern is the 100% pledge of promoter shareholding, reportedly to secure non-convertible debentures (NCDs) for promoter-level acquisitions. This poses a risk of ownership change or forced liquidation if debt servicing at the promoter level falters. Additionally, the company is 100% dependent on imported boron ore, exposing it to global price volatility and foreign exchange risks. Planned dividends and capex may also reduce the company's substantial cash reserves.
Peer comparison
While specific peer data was not provided in the filing, Indo Borax operates in a niche market with a substantial market share in its key segments, suggesting a competitive advantage. Its standalone debt-free status and strong cash reserves differentiate it from companies with higher leverage.
Context metrics (time-bound)
- Revenue grew by approximately 23% in FY26 compared to FY25.
- EBITDA margins decreased from 26.18% in FY25 to 20.50% in FY26.
- Company held ₹2,638 million in cash as of FYE26.
- Planned Capex: ₹900 million over FY27-FY28.
- Promoter NCD debt stands at ₹2,550 million, due in FY31.
What to track next
Investors should monitor the execution of the planned capacity expansion and its impact on future revenues and profitability. Crucially, they need to track how the management addresses the promoter-level debt servicing and the risk associated with the pledged promoter shares. The company's ability to maintain its strong liquidity while funding expansion and dividends will also be key.
